EDUCATION

• 09/2013-06/2016 , Ph.D in Endocrinology and Metabolism Shanghai Jiaotong University, Shanghai, 200025, P.R. China  Advisor: Wei Liu

• 09/2005-06/2007N , M.S. in Endocrinology and Metabolism Shanghai Jiaotong University, Shanghai, 200025, P.R. China  Advisor: Wei Liu

• 09/2000-06/2005 , B.S. in Medicine Shanghai Jiaotong University, Shanghai, 200025, P.R. China

CLINICAL EXPERIENCE

• 12/2019- Associate chief physician Dept. of Endocrinology and Metabolism, Renji Hospital, Shanghai Jiaotong University, School of medicine

• 12/2014-11/2019 Attending physician Dept. of Endocrinology and Metabolism, Dept. of Health Care Center, Renji Hospital, Shanghai Jiaotong University, School of medicine

• 07/2007-11/2014 Resident physician Dept. of Endocrinology and Metabolism, Dept. of Health Care Center, Renji Hospital, Shanghai Jiaotong University, School of medicine

RESEARCH INTERESTS

• Metabolic disorders and reproductive dysfunction；

• Lipidomics, esp., metabolism of fatty acids

GRANTS

National Natural Science Fund of China

01/01/2020-12/31/2022

Title：The effect of 15-deoxy-Δ12,14-prostaglandin J2 on follicular development in patients with PCOS via regulation of autophagy in granulosa cells.

NO. 31900821

Publications

1. Feng Y, Qi J, Xue X, Li X, Liao Y, Sun Y, Tao Y, Yin H, Liu W, Li S, Huang R#. Follicular free fatty acid metabolic signatures and their effects on oocyte competence in non-obese PCOS patients. Reproduction. 2022; 164(1):1~8.

2. Wang Y, Huang R*, Li X, Zhu Q, Liao Y, Tao T, Kang X, Liu W, Li S, Sun Y. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study.Gynecol Endocrinol. 2019;35(12):1072-1077.

3. Huang R, Xue X, Li S, Wang Y, Sun Y, Liu W, Yin H, Tao T. Alterations of polyunsaturated fatty acid metabolism in ovarian tissues of polycystic ovary syndrome rats , J Cell Mol Med, 2018, 22(7): 3388~3396.

4. Liao Y, Huang R*, Sun Y, Yue J, Zheng J, Wang L, Tao T, Ma J, Li S, Liu W. An inverse association between serum soluble receptor of advancedglycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients, Reprod Biol Endocrinol, 2017, 15(1): 9.

5. Huang R, Yue J, Sun Y, Zheng J, Tao T, Li S , Liu W. Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume, Clin Chim Acta, 2015, 450: 366~369.

6. Huang R, Zheng J, Li S, Tao T, Ma J, Liu W. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome, Acta Obstet Gynecol Scand, 2015, 94(5):494~500.

7. Huang R, Gu J, Cao Q, Ma J, Gu W, Fan Z. The association between serum cystatin C and carotid intima–media thickness in metabolic syndrome patients with normal estimated glomerular filtration rate. Clinica Chimica Acta. 2015; 448:170~173.

8. Huang R, Zheng J, Li S, Tao T, Liu W. Subclinical hypothyroidism in patients with polycystic ovary syndrome: Distribution and its association with lipid profiles, Eur J Obstet Gynecol Reprod Biol, 2014, 177: 52~56.